Subscribe Register Login

Thursday, October 27, 2016, 2:07 p.m.
Top Picks - Mobile App

Jury rules against drug company in Arkansas trial

By The Associated Press

This article was published April 10, 2012 at 4:41 p.m.

— Jurors have ruled against a Johnson & Johnson subsidiary in Arkansas’ billion-dollar lawsuit over the antipshychotic drug Risperdal.

Arkansas contended Janssen Pharmaceuticals Inc. downplayed and hid risks associated with Risperdal. Jurors returned their verdict in favor of the state on Tuesday afternoon.

The penalty will be decided in a separate hearing before a judge.

John Lynch will have the details in tomorrow's Arkansas Democrat-Gazette.

Thank you for coming to the website of the Arkansas Democrat-Gazette. We're working to keep you informed with the latest breaking news.


Comments on: Jury rules against drug company in Arkansas trial

To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Read our Terms of Use policy.

Subscribe Register Login

You must login to make comments.



Top Picks - Mobile App
Arkansas Online